Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.
Among other topics, conversations at the meeting focused on new methods for measuring proteins as well as opportunities for automation and AI.
The test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.
Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...
In deference to the occasion, Proteomics International Laboratories (ASX:PIQ) has gone a step further and has launched its ...
PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...
Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT ...
Social isolation and loneliness scores were calculated for each individual and a high-throughput proteomics platform from Olink was used to analyze the blood samples and identify any proteins ...